COSVAC Study - Expression of Interest

University of Adelaide researchers, led by Associate Professor Grubor-Bauk and Professor Gowans, have developed an Omicron COVID-19 Booster vaccine and are calling for healthy volunteers who were previously fully immunised with either AstraZeneca or Pfizer COVID-19 vaccines. 

The Omicron COVID-19 vaccine was manufactured in Adelaide and will be delivered to participants needle-free. This study will be undertaken at the Royal Adelaide Hospital (RAH). Your participation in this study will benefit development of vaccines against SARS-CoV-2 variants, such as the Omicron variant. 

If you would like to express your interest to join the study, please fill your details below and a member of the PARC Clinical Research team from RAH will contact you for a telephone screening. Please contact PARC at (08) 7074 4404 or Health.PARCResearch@sa.gov.au should you have any further enquiries. 

Which of the following vaccines you received as a first dose?
Which of the following vaccines you received as a second dose?
Which of the following vaccines you received as a third dose?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Disclaimer:

The study is only recruiting participants who have had:

  1. Three doses of Pfizer vaccine, or
  2. Two doses of AstraZeneca vaccine and a Pfizer vaccine as a booster.

At the present time, the study is not seeking participants who have received Moderna COVID-19 vaccine.

SA Health